Diffuse Optical Monitoring With Inhaled Nitric Oxide
Status:
Recruiting
Trial end date:
2021-07-01
Target enrollment:
Participant gender:
Summary
This study is a non-randomized, Phase 2 clinical trial designed to measure the cerebral blood
flow (CBF) response to inhaled nitric oxide in acute ischemic stroke patients and healthy
subjects. The monitoring is a 35 minute session during which cerebral hemodynamics will be
monitored with both diffuse correlation spectroscopy (DCS) and transcranial doppler
ultrasonography (TCD) while blood pressure, heart rate, cardiac output, respiratory rate, end
oxygen saturation, and inhaled nitric oxide (NO)/nitrogen dioxide (NO2) concentration, are
continuously monitored.